Xibrom
- Generic Name: bromfenac ophthalmic solution
- Brand Name: Xibrom
Xibrom (Bromfenac Ophthalmic Solution ) side effects drug center
- Related Drugs
- Xibrom User Reviews
Xibrom Side Effects Center
What Is Xibrom?
Xibrom (bromfenac ophthalmic solution) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat swelling and pain caused by cataract surgery.
What Are Side Effects of Xibrom?
Common side effects of Xibrom include:
- temporary irritation/burning/stinging of the eye when you apply the eye drops,
- itchy eyes,
- temporary blurred vision,
- watery eyes,
- headache, or
- seeing flashes of light or "floaters" in your vision
Dosage for Xibrom
For the treatment of postoperative inflammation in patients who have undergone cataract extraction, the recommended dose of Xibrom ophthalmic solution is one drop applied to the affected eye(s) two times daily beginning 24 hours after cataract surgery and continuing through the first 2 weeks of the postoperative period.
What Drugs, Substances, or Supplements Interact with Xibrom?
Xibrom may interact with steroids. Other drugs may interact with Xibrom ophthalmic. Tell your doctor all prescription and over-the-counter medications and supplements you use.
Xibrom During Pregnancy or Breastfeeding
During pregnancy, Xibrom should be used only when prescribed. It is not recommended for use during the last 3 months of pregnancy due to possible harm to a fetus and interference with normal labor/delivery. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Additional Information
Our Xibrom (bromfenac ophthalmic solution) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Xibrom Consumer Information
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
- any change in your vision;
- slow healing after your eye surgery;
- eye redness or bleeding;
- eye pain or swelling; or
- severe eye discomfort, increased tears, crusting or drainage.
Common side effects may include:
- increased sensitivity of your eyes to light;
- mild eye irritation, or feeling like something is in your eye;
- headache; or
- seeing flashes of light or "floaters" in your vision.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Xibrom (Bromfenac Ophthalmic Solution )
Xibrom Professional Information
SIDE EFFECTS
Clinical Trial Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
The most commonly reported adverse reactions reported following use of bromfenac after cataract surgery include: abnormal sensation in eye, conjunctival hyperemia, eye irritation (including burning/stinging), eye pain, eye pruritus, eye redness, headache, and iritis. These reactions were reported in 2 to 7% of patients.
Post-Marketing Experience
The following reactions have been identified during post-marketing use of bromfenac ophthalmic solution 0.09% in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to topical bromfenac ophthalmic solution 0.09% or a combination of these factors, include corneal erosion, corneal perforation, corneal thinning, and epithelial breakdown [see WARNINGS AND PRECAUTIONS].
Read the entire FDA prescribing information for Xibrom (Bromfenac Ophthalmic Solution )
&Copy; Xibrom Patient Information is supplied by Cerner Multum, Inc. and Xibrom Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.